$HRMY Harmony Biosciences is now acquiring a microcap $ZYNE that was at -30 cents. Never a good sign when a one-product pharma co diversifies into a random cannabis-based topical gel, esp one with a long history of utter trial failures. The timing of the diversification…
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.